Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis.
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
The effects of plasminogen activator inhibitor-1 (PAI-1) gene inactivation on hemostasis, thrombosis and thrombolysis were studied in homozygous PAI-1-deficient (PAI-1-/-) mice, generated by homologous recombination in D3 embryonic stem cells. Diluted (10-fold) whole blood clots from PAI-1-/- and from PAI-1 wild type (PAI-1+/+) mice underwent limited but significantly different (P < 0.001) spontaneous lysis within 3 h (6 +/- 1 vs 3 +/- 1%, respectively). A 25-microliters 125I-fibrin-labeled normal murine plasma clot, injected into a jugular vein, was lysed for 47 +/- 5, 66 +/- 3, and 87 +/- 7% within 8 h in PAI-1+/+, heterozygous PAI-1-deficient (PAI-1+/-), and PAI-1-/- mice, respectively (P = 0.002 for PAI-1+/+ vs PAI-1-/- mice). Corresponding values after pretreatment with 0.5 mg/kg endotoxin in PAI-1+/+ and PAI-1-/- mice, were 35 +/- 5 and 91 +/- 3% within 4 h, respectively (P < 0.001). 11 out of 26 PAI-1+/+ but only 1 out of 25 PAI-1-/- mice developed venous thrombosis (P = 0.004) within 6 d after injection of 10 or 50 micrograms endotoxin in the footpad. Spontaneous bleeding or delayed rebleeding could not be documented in PAI-1-/- mice after partial amputation of the tail or of the caecum. Thus, disruption of the PAI-1 gene in mice appears to induce a mild hyperfibrinolytic state and a greater resistance to venous thrombosis but not to impair hemostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
Hamsten, A., Walldius, G., Szamosi, A., Blombäck, M., Faire, U., Dahlén, G., Landou, C., & Wiman, B. (1987) · The Lancet · doi:10.1016/s0140-6736(87)93050-9 · Cited by 1,474
Plasminogen activator inhibitors
Sprengers, E., & Kluft, C. (1987) · Blood · doi:10.1182/blood.v69.2.381.381 · Cited by 1,009
Juhan-Vague, I., Alessi, M. C., & Vague, P. (1991) · Diabetologia · doi:10.1007/bf00403280 · Cited by 567
Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries.
Schneiderman, J., Sawdey, M. S., Keeton, M. R., Bordin, G. M., Bernstein, E. F., Dilley, R. B., & Loskutoff, D. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.6998 · Cited by 543
Sawdey, M. S., & Loskutoff, D. J. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115440 · Cited by 410
Colucci, M., Paramo, J. A., & Collen, D. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111777 · Cited by 390
Self-citationCarmeliet, P., Kieckens, L., Schoonjans, L., Ream, B., van Nuffelen, A., Prendergast, G., Cole, M., Bronson, R., Collen, D., & Mulligan, R. C. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116892 · Cited by 345
Self-citationNilsson, I. M., Ljungnér, H., & Tengborn, L. (1985) · BMJ · doi:10.1136/bmj.290.6480.1453 · Cited by 336
Plasminogen activator inhibitor in the blood of patients with coronary artery disease.
Paramo, J. A., Colucci, M., Collen, D., & van de Werf, F. (1985) · BMJ · doi:10.1136/bmj.291.6495.573 · Cited by 302
Self-citationComplete Deficiency of Plasminogen-Activator Inhibitor Type 1 Due to a Frame-Shift Mutation
Fay, W. P., Shapiro, A. D., Shih, J. L., Schleef, R. R., & Ginsburg, D. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212103272406 · Cited by 271
Cited by
The urokinase-type plasminogen activator system in cancer metastasis: A review
Andreasen, P. A., Kjøller, L., Christensen, L., & Duffy, M. J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970703)72:1<1::aid-ijc1>3.0.co;2-z · Cited by 1,546
Physiological consequences of loss of plasminogen activator gene function in mice
Carmeliet, P., Schoonjans, L., Kieckens, L., Ream, B., Degen, J., Bronson, R., De Vos, R., van den Oord, J. J., Collen, D., & Mulligan, R. C. (1994) · Nature · doi:10.1038/368419a0 · Cited by 1,037
Self-citationThe plasminogen activation system in tumor growth, invasion, and metastasis
Andreasen, P. A., Egelund, R., & Petersen, H. H. (2000) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180050497 · Cited by 943
Molecular mechanisms of fibrinolysis
Cesarman‐Maus, G., & Hajjar, K. A. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05444.x · Cited by 748
Eriksson, P., Kallin, B., van 't Hooft, F. M., Båvenholm, P., & Hamsten, A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.1851 · Cited by 739
Ghosh, A. K., & Vaughan, D. E. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.22783 · Cited by 679
Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization
Bajou, K., Noël, A., Gerard, R. D., Masson, V., Brunner, N., Holst-Hansen, C., Skobe, M., Fusenig, N. E., Carmeliet, P., Collen, D., et al. (1998) · Nature Medicine · doi:10.1038/nm0898-923 · Cited by 677
Self-citationEitzman, D. T., McCoy, R. D., Zheng, X., Fay, W. P., Shen, T., Ginsburg, D., & Simon, R. H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118396 · Cited by 558
Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration
Chapman, H. A. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80126-3 · Cited by 464
Loss of Fibrinogen Rescues Mice from the Pleiotropic Effects of Plasminogen Deficiency
Bugge, T. H., Kombrinck, K. W., Flick, M. J., Daugherty, C. C., Danton, M. J. S., & Degen, J. L. (1996) · Cell · doi:10.1016/s0092-8674(00)81390-2 · Cited by 424
Effects of Disruption of The Plasminogen Gene on Thrombosis, Growth, and Health in Mice
Ploplis, V. A., Carmeliet, P., Vazirzadeh, S., Van Vlaenderen, I., Moons, L., Plow, E. F., & Collen, D. (1995) · Circulation · doi:10.1161/01.cir.92.9.2585 · Cited by 386
Self-citationKleinschnitz, C., Pozgajova, M., Pham, M., Bendszus, M., Nieswandt, B., & Stoll, G. (2007) · Circulation · doi:10.1161/circulationaha.107.691279 · Cited by 379
Long-Term Antithrombotic Protection by in Vivo Depletion of Platelet Glycoprotein VI in Mice
Nieswandt, B., Schulte, V., Bergmeier, W., Mokhtari-Nejad, R., Rackebrandt, K., Cazenave, J.-P., Ohlmann, P., Gachet, C., & Zirngibl, H. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.4.459 · Cited by 362
Carmeliet, P., Kieckens, L., Schoonjans, L., Ream, B., van Nuffelen, A., Prendergast, G., Cole, M., Bronson, R., Collen, D., & Mulligan, R. C. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116892 · Cited by 345
Self-citationBajou, K., Masson, V., Gerard, R. D., Schmitt, P. M., Albert, V., Praus, M., Lund, L. R., Frandsen, T. L., Brunner, N., Dano, K., et al. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.4.777 · Cited by 314
Self-citationPleiotropic functions of plasminogen activator inhibitor-1
LIJNEN, H. R. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00827.x · Cited by 312
Samad, F., Yamamoto, K., & Loskutoff, D. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118404 · Cited by 301
Historical analysis of PAI-1 from its discovery to its potential role in cell motility and disease
Dellas, C., & Loskutoff, D. J. (2005) · Thrombosis and Haemostasis · doi:10.1160/th05-01-0033 · Cited by 285
Holtkötter, O., Nieswandt, B., Smyth, N., Müller, W., Hafner, M., Schulte, V., Krieg, T., & Eckes, B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112307200 · Cited by 274
Feener, E. P., Northrup, J. M., Aiello, L. P., & King, G. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117786 · Cited by 255
Nagai, N., De Mol, M., Lijnen, H. R., Carmeliet, P., & Collen, D. (1999) · Circulation · doi:10.1161/01.cir.99.18.2440 · Cited by 252
Self-citationYAMAMOTO, K., TAKESHITA, K., KOJIMA, T., TAKAMATSU, J., & SAITO, H. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.11.013 · Cited by 214
Zhang, H., Sachdev, P. S., Wen, W., Crawford, J. D., Brodaty, H., Baune, B. T., Kochan, N. A., Slavin, M. J., Reppermund, S., Kang, K., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.10.008 · Cited by 32
Elbasty, A., & Metcalf, J. (2017) · Vascular Specialist International · doi:10.5758/vsi.2017.33.4.121 · Cited by 8
Metadata
- Authors
- Carmeliet, P., Stassen, J. M., Schoonjans, L., Ream, B., van den Oord, J. J., De Mol, M., Mulligan, R. C., & Collen, D.
- Venue
- Journal of Clinical Investigation
- Published
- 1993-12-01
- Volume
- 92
- Issue
- 6
- Pages
- 2756-2760
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2032102036
- Cited by
- 388
- References
- 21
- FWCI
- 11.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.